SyntekaBio Inc (226330) — Capital Reinvestment Ratio

Latest as of December 2019: 0.06x

SyntekaBio Inc (226330) has a Capital Reinvestment Ratio of 0.06x as of December 2019, meaning it reinvests 0% of its operating cash flow (₩15.10 Billion) in capital expenditures (₩924.66 Million). Check 226330 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

₩15.10 Billion

KRW

Capital Expenditures

₩924.66 Million

KRW

Data as of

Dec 2019

Most recent filing

Annual Capital Reinvestment Ratio for SyntekaBio Inc (None–None)

Year-by-year Capital Reinvestment Ratio for SyntekaBio Inc from None to None. See how much free cash does SyntekaBio Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow